Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 27 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pediatric Liver Transplantation Clear all

Conditions: Liver Transplantation, Thymoglobulin, Rejection
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: Up to 21 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Exocrine Pancreatic Insuficiency
Interventions: Fecal Fat; Diagnostic Test
Lead sponsor: Digestive Care, Inc.; Industry
Eligibility: 7 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 9
States / cities: Aurora, Colorado • Washington D.C., District of Columbia • New York, New York + 6 more

Conditions: Veno-occlusive Disease
Interventions: Defibrotide, Best Supportive Care; Drug · Other
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 1 Month and older
Enrollment: 372 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 37
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 29 more

Conditions: Liver Transplantation, Liver Diseases
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: Up to 70 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 8
States / cities: Los Angeles, California • Palo Alto, California • San Francisco, California + 5 more

Conditions: Influenza
Interventions: Trivalent Subviron Influenza vaccine (Fluzone); Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Months to 17 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: New York, New York

Conditions: Liver Disease, Liver Transplant
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: Up to 18 Years
Enrollment: 401 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2016
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Pediatric Liver Transplanted Recipients
Interventions: Health advocate, Enhanced Control; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 0 Years to 18 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: San Francisco, California • Pittsburgh, Pennsylvania

Conditions: Liver Transplantation
Interventions: tacrolimus modified release (MR), tacrolimus; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: Up to 12 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 5
States / cities: Atlanta, Georgia • Indianapolis, Indiana • New Orleans, Louisiana + 2 more

Conditions: Heart Transplant Infection, Kidney Transplant Infection, Liver Transplant Infection, CMV
Interventions: CMV T cell Immunity Assay; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 0 Years to 17 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 12
States / cities: Stanford, California • Atlanta, Georgia • Chicago, Illinois + 9 more

Conditions: Hemorrhage
Interventions: TachoSil®, Surgicel® Original; Biological · Device
Lead sponsor: Takeda; Industry
Eligibility: Not listed
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 17
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Chicago, Illinois + 14 more

Conditions: End-stage Liver Disease, Renal Insufficiency, Renal Failure
Interventions: mycophenolate mofetil, placebo medication; Drug · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 16 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hepatoblastoma, Hepatocellular Carcinoma, Rhabdoid Tumor of Liver, Undifferentiated (Embryonal) Sarcoma of the Liver, Pediatric Liver Cancer, Liver Tumors
Interventions: Quality of Life Assessment, Transarterial Radioembolization; Behavioral · Radiation
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 0 Years to 21 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Wilmington, Delaware • Jacksonville, Florida

Conditions: Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic, Bone Marrow Transplant Complications, Stem Cell Transplant Complications
Interventions: Ultrasound Elastography, Contrast Enhanced Ultrasound (CEUS); Diagnostic Test · Drug
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 1 Month to 25 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Nonadherence, Tacrolimus, Pediatric Liver Transplant Recipients
Interventions: Telemetric; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 11 Years to 19 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Los Angeles, California • Cincinnati, Ohio • Pittsburgh, Pennsylvania

Conditions: RENAL INSUFFICIENCY, CHRONIC, LIVER FAILURE, ACUTE, HEART DISEASE
Interventions: ProQuad; Biological
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 6 Months to 24 Months
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Heart-Lung Transplantation
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 11 Years to 18 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Behavior and Behavior Mechanisms
Interventions: Peer Mentoring, e-Communication with mentor; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 14 Years to 23 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Chordoma, Kidney Cancer, Liver Cancer, Neuroblastoma, Ovarian Cancer, Retinoblastoma, Sarcoma
Interventions: amifostine trihydrate, busulfan, filgrastim, melphalan, thiotepa, peripheral blood stem cell transplantation (PBSC); Drug · Procedure
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 1 Year to 45 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2003
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Liver Transplant; Complications, Quality of Life, Child Behavior, Adolescent Behavior
Interventions: PeLTQL delivery via electronic means; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 8 Years to 20 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 6
States / cities: Oakland, California • Atlanta, Georgia • New York, New York + 2 more

Conditions: Kidney Transplantation, Liver Transplantation, Heart Transplantation
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: Up to 21 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Sinusoidal Obstruction Syndrome
Interventions: Serial Blood Draws; Other
Lead sponsor: Indiana University; Other
Eligibility: Up to 25 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Indianapolis, Indiana • Ann Arbor, Michigan + 1 more

Conditions: Pediatric Liver Transplantation
Interventions: Corticosteroids, Cyclosporine, mycophenolate mofetil; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 3 Months to 12 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 2
States / cities: San Francisco, California • New York, New York

Conditions: Liver Transplant, Liver Transplantation
Interventions: Immunosuppression Withdrawal; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 4 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2017
U.S. locations: 3
States / cities: San Francisco, California • Chicago, Illinois • New York, New York

Conditions: Pediatric Recipients of a Liver Transplant
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 1 Year to 18 Years
Enrollment: 401 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 5
States / cities: Los Angeles, California • Chicago, Illinois • New York, New York + 2 more

Search by objective public record fields.

rATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

Social & Contextual Impact on Children Undergoing Liver Transplantation

Influenza Vaccine in Pediatric Transplant Subjects

Pediatric Liver Database

Health Advocate for Children After Liver Transplant

A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery

Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients

Improving Medication-taking After Liver Transplant

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Quality of Life in Pediatric Transplant Recipients

Peers for Promoting Adolescent Transplant Health

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Starzl Network Patient Reported Outcomes

Quality of Life in Pediatric Transplant Patients

Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study

Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

Medication Adherence in Children Who Had a Liver Transplant